Published in Br J Cancer on January 16, 2006
Genetic pathways to primary and secondary glioblastoma. Am J Pathol (2007) 9.27
The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma. Springerplus (2014) 1.46
Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res (2007) 1.42
Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma. BMC Cancer (2010) 1.37
Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma. PLoS One (2013) 0.96
High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol Ther (2009) 0.93
Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines. Mol Cancer (2008) 0.90
Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma. Virchows Arch (2012) 0.86
Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins. Onco Targets Ther (2014) 0.85
In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide. Nanoscale Res Lett (2014) 0.83
Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells. Cell Death Dis (2015) 0.83
Association of survivin splice variants with prognosis and treatment of breast cancer. World J Clin Oncol (2014) 0.81
Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients. Exp Ther Med (2010) 0.80
Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. Cancer Gene Ther (2014) 0.79
Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J Gastroenterol (2011) 0.78
Downregulated expression of peroxiredoxin 4 in granulosa cells from polycystic ovary syndrome. PLoS One (2013) 0.77
Tumour-specific triple-regulated oncolytic herpes virus to target glioma. Oncotarget (2016) 0.76
Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression. Oncol Lett (2014) 0.76
Survivin and gliomas: A literature review. Oncol Lett (2016) 0.75
Correlation of survivin and B-cell lymphoma 2 expression with pathological malignancy and anti-apoptotic properties of glial cell tumors. Biomed Rep (2017) 0.75
Unique spectral markers discern recurrent Glioblastoma cells from heterogeneous parent population. Sci Rep (2016) 0.75
Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis. Neural Regen Res (2012) 0.75
Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma. Oncol Lett (2017) 0.75
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med (1997) 12.65
Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol Biol Cell (2003) 4.28
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol (2000) 4.27
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res (1998) 3.63
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry (2001) 3.05
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol (1998) 2.64
A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol (1999) 2.32
The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer (1999) 2.12
Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer (2001) 2.10
A p34(cdc2) survival checkpoint in cancer. Cancer Cell (2002) 1.99
Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol (2002) 1.74
Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett (2001) 1.56
Prognostic importance of survivin in breast cancer. Br J Cancer (2003) 1.56
Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ (2002) 1.50
Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer (2003) 1.35
Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.33
Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol (2003) 1.20
Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res (1998) 1.18
Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol (2002) 1.10
Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol (2005) 1.09
Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer (2003) 1.06
Expression of survivin in primary glioblastomas. J Cancer Res Clin Oncol (2002) 1.06
Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J Neuropathol Exp Neurol (2000) 1.04
Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer (2004) 1.03
Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels. Arch Pathol Lab Med (2003) 0.92
Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis. Gynecol Oncol (1997) 0.92
No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol (2005) 0.89
Amplification and overexpression of epidermal growth factor receptor gene in glioblastomas of Chinese patients correlates with patient's age but not with tumor's clinicopathological pathway. Acta Neuropathol (2005) 0.82
Expression of survivin, a novel apoptosis inhibitor and cell cycle regulatory protein, in human gliomas. Chin Med J (Engl) (2004) 0.80
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27
Structure of the bacteriophage phi29 DNA packaging motor. Nature (2000) 5.25
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst (1997) 3.51
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature (1997) 2.93
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70
A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene (1998) 2.39
Regional patterns of soil organic carbon stocks in China. J Environ Manage (2006) 2.21
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J Clin Oncol (1994) 2.10
Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol (1998) 2.07
Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg (1995) 1.99
A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem (1999) 1.92
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res (1996) 1.89
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol (1998) 1.87
Quantitation of RNA polymerase II and its transcription factors in an HeLa cell: little soluble holoenzyme but significant amounts of polymerases attached to the nuclear substructure. Mol Cell Biol (1999) 1.79
Predicting antibody hypervariable loop conformation. I. Ensembles of random conformations for ringlike structures. Biopolymers (1987) 1.78
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer (1993) 1.77
Structure determination of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2001) 1.74
Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood (1995) 1.62
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst (1997) 1.62
Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis (2010) 1.57
Transcription activation via enhanced preinitiation complex assembly in a human cell-free system lacking TAFIIs. Mol Cell (1998) 1.56
Cryoelectron-microscopy image reconstruction of symmetry mismatches in bacteriophage phi29. J Struct Biol (2001) 1.54
The boomerang flap in managing injuries of the dorsum of the distal phalanx. Plast Reconstr Surg (2000) 1.52
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer (1993) 1.52
Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr (1995) 1.47
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene (2006) 1.45
Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer (2007) 1.45
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res (1995) 1.44
Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr (1997) 1.43
New hypothesis of chronic back pain: low pH promotes nerve ingrowth into damaged intervertebral disks. Acta Anaesthesiol Scand (2012) 1.43
Endoscopically-assisted adipofascial flap harvest for soft tissue defects of the lower leg. Br J Plast Surg (1998) 1.42
Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery (1997) 1.40
Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences. Proc Natl Acad Sci U S A (1999) 1.39
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci U S A (1998) 1.37
Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Rapid generation of region specific probes by chromosome microdissection and their application. Nat Genet (1992) 1.35
The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol (1992) 1.35
Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr (1994) 1.34
Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev (1999) 1.30
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Positive and negative TAF(II) functions that suggest a dynamic TFIID structure and elicit synergy with traps in activator-induced transcription. Mol Cell Biol (2001) 1.26
The OrthoChina project. J Bone Joint Surg Br (2007) 1.26
Role of NBCe1 and AE2 in secretory ameloblasts. J Dent Res (2008) 1.25
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res (1999) 1.25
Chromosome arm painting probes. Nat Genet (1996) 1.24
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer. J Clin Oncol (1993) 1.24
Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol (2001) 1.24
Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23
Cellular uptake of amelogenin, and its localization to CD63, and Lamp1-positive vesicles. Cell Mol Life Sci (2007) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22
Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab (2001) 1.22
Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene (2006) 1.22
Novel cofactors and TFIIA mediate functional core promoter selectivity by the human TAFII150-containing TFIID complex. Mol Cell Biol (1998) 1.21
Intracranial dural arteriovenous fistulas with or without cerebral sinus thrombosis: analysis of 69 patients. J Neurol Neurosurg Psychiatry (2004) 1.21
The physical activity transition among adults in China: 1991-2011. Obes Rev (2014) 1.20
Telomere capture stabilizes chromosome breakage. Nat Genet (1993) 1.18
Psychological functioning of daughters of breast cancer patients. Part II: Characterizing the distressed daughter of the breast cancer patient. Psychosomatics (1992) 1.18
Disaster epidemiology and medical response in the Chi-Chi earthquake in Taiwan. Ann Emerg Med (2001) 1.16
Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet (1996) 1.15
NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ (1999) 1.15
Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer. Br J Radiol (2004) 1.13
Gene transcription and chromosome replication in Escherichia coli. J Bacteriol (1997) 1.12
Implementation of a primary care physician network obesity management program. Obes Res (2001) 1.11
Autocloning and amplification of LIP2 in Yarrowia lipolytica. Appl Environ Microbiol (2000) 1.10
Reconstruction of burn scar of the upper extremities with artificial skin. Plast Reconstr Surg (2001) 1.10
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res (2001) 1.09
Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog (2005) 1.08
Modulation of stress protein (hsp27 and hsp70) expression in CD4+ lymphocytic cells following acute infection with human immunodeficiency virus type-1. Virology (1997) 1.08
Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patients. Am J Gastroenterol (1997) 1.07
Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC. J Clin Oncol (1993) 1.07
Duodenal perforation as a complication of routine endoscopic nasoenteral feeding tube placement. Burns (1999) 1.07
Osteoporosis in china. Osteoporos Int (2009) 1.06
Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage (2007) 1.06
Shed tumor gangliosides and progression of human neuroblastoma. Blood (1990) 1.05
Purification, crystallization and initial X-ray analysis of the head-tail connector of bacteriophage phi29. Acta Crystallogr D Biol Crystallogr (2000) 1.05
Toll-like receptors 2 and 4 gene polymorphisms in a southeastern Chinese population with tuberculosis. Int J Immunogenet (2009) 1.05
A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood (1990) 1.05
Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Obes Res (2001) 1.04
Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell Dev Biol Anim (2001) 1.04
Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention. Cancer (1995) 1.04
The significance of LMO2 expression in the progression of prostate cancer. J Pathol (2007) 1.02
Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer (2000) 1.02
A single peripheral injection of basic fibroblast growth factor (bFGF) stimulates granule cell production and increases cerebellar growth in newborn rats. J Neurobiol (2001) 1.02
EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett (2001) 1.01
Negatively charged nitrogen-vacancy centers in a 5 nm thin 12C diamond film. Nano Lett (2013) 1.01
Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet (1994) 1.01
Expression of the zinc finger gene EVI-1 in ovarian and other cancers. Br J Cancer (1996) 1.01
Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood (1991) 1.00
Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and "multidimensionally impaired". Am J Med Genet (1998) 1.00
Prediction of hybrid performance in grain sorghum using RFLP markers. Theor Appl Genet (2002) 1.00
A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res (2000) 1.00
China in the period of transition from scarcity and extensive undernutrition to emerging nutrition-related non-communicable diseases, 1949-1992. Obes Rev (2014) 0.99
Effect of lanthanide chloride on photosynthesis and dry matter accumulation in tobacco seedlings. Biol Trace Elem Res (2001) 0.99
Snapshots of Dirac fermions near the Dirac point in topological insulators. Nano Lett (2013) 0.99